1-4 of 4
Kantarjian Hagop
Close
Sort by
Journal Articles

Prognostic Factors for Outcome in Patients (pts) with Refractory and Relapsed Acute Lymphocytic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (IO), a CD22 Monoclonal Antibody

Elias Jabbour, MD, Susan O'Brien, MD, Koji Sasaki, Xuelin Huang, PhD, Deborah A. Thomas, MD, Michael E. Rytting, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Pierce Sherry, RN, Tapan M. Kadia, MD, Kantarjian Hagop, MD
Journal: Blood
Blood (2014) 124 (21): 2288.
https://doi.org/10.1182/blood.V124.21.2288.2288
Published: 2014
Journal Articles

Phase II Study Of The Hyper-CVAD Regimen In Combination With Ofatumumab As Frontline Therapy For Adults With CD-20 Positive Acute Lymphoblastic Leukemia (ALL)

Elias Jabbour, MD, Kantarjian Hagop, MD, Deborah Thomas, MD, Guillermo Garcia-Manero, MD, Daniela Hoehn, MD, PhD, Rebecca Garris, BSc, Stefan H. Faderl, MD, Jorge E. Cortes, MD, Tapan M. Kadia, MD, Farhad Ravandi, MD, Srdan Verstovsek, MD, PhD, Susan O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): 2664.
https://doi.org/10.1182/blood.V122.21.2664.2664
Published: 2013
Journal Articles

Incidence Of and Risk Factors For Acute Myeloid Leukemia Involvement Of The Central Nervous System

Rozovski Uri, MD, Maro Ohanian, DO, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Stefan H. Faderl, MD, Jorge E. Cortes, MD, Sherry R. Pierce, RN, BS, Kantarjian Hagop, MD, Zeev Estrov, MD
Journal: Blood
Blood (2013) 122 (21): 3883.
https://doi.org/10.1182/blood.V122.21.3883.3883
Published: 2013
Journal Articles

A Pooled Overall Survival Analysis of The COMFORT Studies: 2 Randomized Phase 3 Trials of Ruxolitinib For The Treatment of Myelofibrosis

Alessandro M. Vannucchi, MD, Kantarjian Hagop, Jean-Jacques Kiladjian, MD, PhD, Jason Gotlib, MD, MS, Francisco Cervantes, MD, PhD, Ruben A. Mesa, MD, Giovanni Barosi, MD, Nicholas Sarlis, Wei Peng, PhD, Victor A. Sandor, MD, CM, Andres Sirulnik, MD, PhD, Abdel Hmissi, Viktoriya Stalbovskaya, PhD, Vikas Gupta, MD, FRCP, FRCPath, Claire N Harrison, DM, FRCP, FRCPath, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2820.
https://doi.org/10.1182/blood.V122.21.2820.2820
Published: 2013